Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 5, 2005, Pages 719-722

  Hiraga, Akiyuki ^a,b   Mori, M ^b   Ogawara, K ^b   Kojima, S ^c   Kanesaka, T ^b   Misawa, S ^b   Hattori, T ^b   Kuwabara, S ^b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Matsudo City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONVALESCENCE; ELECTRODIAGNOSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; WALKING;

ADOLESCENT; ADULT; AGED; AXONS; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; GAIT DISORDERS, NEUROLOGIC; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; PROGNOSIS; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX;

EID: 17644403098     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.051136     Document Type: Article

References (31)

1. Feosby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barre palneuropathy. Brain 1986;109:1115-26.
2. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-42.
3. Griffin JW, Li CY, Ho TW, et al. Guillain-Barre syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-95.
4. Ho TW, Mishu B, Li CY, et al. Guillain-Barre syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
5. Visser LH, van der Meche FGA, van Doom PA, et al. Guillain-Barre syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995;118:841-7.
6. Rees JH, Soudain SE, Gregson NA, et al. Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl J Med 1995;333:1374-9.
7. Lyu R-K, Tang L-M, Cheng S-Y, et al. Guillain-Barre syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997;63:494-500.
8. Emilia-Romogna Study Group. A prospective study on the incidence and prognosis of Guillain-Barre syndrome in Emilia-Romagna region, Italy (1992-1993). Neurology 1997;48:214-21.
9. Kuwabara S, Asahina M, Koga M, et al. Two patterns of clinical recovery in Guillain-Barre syndrome with IgG anti-GM1 antibody. Neurology 1998;51:1656-60.
10. Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barre syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000;48:624-31.
11. Chio A, Cocito D, Leone M, et al. Guillain-Barre syndrome: a prospective, population-based incidence and outcome survey. Neurology 2003;60:1146-50.
12. Dourado ME, Duarte RC, Ferreira LC, et al. Anti-ganglioside antibodies and clinical outcome of patients with Guillain-Barre syndrome in northeast Brazil. Ada Neurol Stand 2003;108:102-8.
13. McKhann GM, Griffin JW, Cornblath DR, et al. Plasmapheresis and Guillain-Barre syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988;23:347-53.
14. Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988;51:605-12.
15. The Italian Guillain-Barre Study Group. The prognosis and main prognostic indicators of Guillain-Barre syndrome. A multicentre prospective study of 297 patients. Brain 1996;119:2053-61.
16. Visser LH, Schmitz PIM, Meulstee J, et al. Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange. Neurology 1999;53:598-604.
17. Haddsn RDM, Karch H, Hartung H-P, et al. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 2001;56:758-65.
18. Comblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barre syndrome: description and prognostic value. Ann Neural 1988;23:354-9.
19. Ho TW, Li CY, Cornblath DR, et al. Patterns of recovery in the Guillain-Barre syndromes. Neurology 1997;48:695-700.
20. Kuwabara S, Ogawara K, Mizobuchi K, et al. Mechanisms of early and late recovery in acute motor axonal neuropathy. Muscle Nerve 2001;24:288-91.
21. Kuwabara S, Mori M, Ogawara K, et al. Indicators of rapid clinical recovery in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2001;70:560-2.
22. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27(suppl):S21-4.
23. Ho TW, Hsieh S-T, Nachamkin I, et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 1997;48:717-24.
24. Kuwabara S, Yuki N, Koga M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome. Ann Neurol 1998;44:202-8.
25. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barre syndrome. Philadelphia: FA Davis, 1991.
26. Rees JH, Thompson RD, Smeeton NC, et al. Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 1998;64-.74-7.
27. Bernsen RAJAM, de Jager AEJ, Schmitz PIM, et al. Long-term impact on work and private life after Guillain-Barre syndrome. J Neurol Sci 2002;201:13-17.
28. 1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-16.
29. Hadden RDM, Cornblath DR, Hughes RAC, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Ann Neurol 1998;44:780-8.
30. Ropper AH. Severe acute Guillain-Barre syndrome. Neurology 1986;36:429-32.
31. Fletcher DD, Lawn ND, Wolter TD, et al. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation. Neurology 2000;54:2311-15.